Legend Biotech (LEGN) Inventory Average (2020 - 2025)
Legend Biotech filings provide 6 years of Inventory Average readings, the most recent being $30.6 million for Q4 2025.
- On a quarterly basis, Inventory Average rose 28.95% to $30.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.6 million, a 28.95% increase, with the full-year FY2025 number at $28.0 million, up 29.0% from a year prior.
- Inventory Average hit $30.6 million in Q4 2025 for Legend Biotech, down from $32.4 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $33.3 million in Q2 2025 to a low of $1898.5 in Q2 2021.
- Median Inventory Average over the past 5 years was $18.7 million (2023), compared with a mean of $16.2 million.
- Biggest five-year swings in Inventory Average: skyrocketed 51320.94% in 2021 and later increased 26.71% in 2024.
- Legend Biotech's Inventory Average stood at $1.7 million in 2021, then skyrocketed by 37.27% to $2.3 million in 2022, then surged by 706.35% to $18.7 million in 2023, then increased by 26.71% to $23.7 million in 2024, then grew by 28.95% to $30.6 million in 2025.
- The last three reported values for Inventory Average were $30.6 million (Q4 2025), $32.4 million (Q3 2025), and $33.3 million (Q2 2025) per Business Quant data.